Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

The Competition Council has authorised the transaction through which Pavăl Holding intends to acquire the Carrefour group in Romania.
Romanian construction company Concelex recorded revenues of RON 1.48 billion (€296 million) in 2025, representing a 17 per cent increase compared to the previous year.
Polytrade Global, a Romanian group specialising in energy infrastructure, the supply of electrical equipment, and renewable energy projects, closed 2025 with a turnover of around €21.5 million, a 173% increase on the previous year, and a net profit of €579,000.
Grup Şerban Holding said its subsidiary Ferma Avicolă Şerban completed the sale to SAGEM of a portfolio of real estate and operating assets located in Bacău and Vaslui counties, consisting of land plots, buildings, installations and equipment related to poultry farming activities.
Romania has recorded the lowest corporate artificial intelligence (AI) adoption rate in Central Europe, with just 5% of companies deploying the technology at an organisational scale.